Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bristol/Sanofi Receive FTC Subpoena Over Failed Plavix Settlement With Apotex

This article was originally published in The Pink Sheet Daily

Executive Summary

Both firms say they will comply with investigation seeking documents.

You may also be interested in...

Sanofi/Bristol Plavix Patent Suit To Begin Against Apotex

With preliminary injunction rulings weighing in Sanofi/Bristol's favor, Apotex's defense will need to make a strong case that clopidogrel patents are invalid.

Brand/Generic Settlements To Be Subject Of Senate Judiciary Hearing

PhRMA is among the parties scheduled to testify at the panel next week, which could coincide with the reintroduction of Sen. Kohl’s bill to curb settlements.

Plavix Sales Plummet With Generic Entry

Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts